CH
Christophe Herkenne
R&D Associate Director at Debiopharm
View Christophe's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Aug 2006 - Present · 18 years and 4 months
R&D Associate Director
Jan 2015 - Present · 9 years and 11 months
R&D Manager
Aug 2013 - Dec 2014 · 1 years and 4 months
Pharmaceutical Project Manager
Aug 2006 - Aug 2013 · 7 years
Company Details
201-500 Employees
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!
Year Founded
1979
Social Media
LinkedinFacebookTwitter
Industry
Pharmaceutical Manufacturing, Pharmaceutical products, Holding companies and groups of companies, Financial and insurance services, Business Services, Scientific Research and Development Services, Services
HQ Location
Chemin Messidor 5-7 Lausanne, 1006, CH
Keywords
rug developmentigital healthoncologytimicrobialsHealthcareBiopharmaceuticalrug deliveryScience and innovatiopathology platformvaccine development
Discover More About Cleveland Clinic

Find verified contacts of Christophe Herkenne in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.